Epilepsy is a chronic neurological disorder marked by abnormal electrical activity in the brain, leading to recurrent seizures that differ widely in type and severity. When medications fail to provide adequate control, many patients explore additional therapies, including vagus nerve stimulation for epilepsy as a potential option for reducing seizure frequency.
What is vagus nerve stimulation?
Vagus nerve stimulation is a treatment that involves implanting a programmable electrical device that sends intermittent electrical pulses to the left vagus nerve in the neck, aiming to modify neural activity in the brain and reduce the frequency of epileptic seizures. This treatment is used as an adjunctive therapy, particularly for patients with drug-resistant epilepsy. It is important to note that it is not a cure or a substitute for medication, but rather a supportive treatment option.
What is drug-resistant epilepsy?
Drug-resistant epilepsy is a condition in which patients experience ongoing seizures despite receiving appropriate medication. Research indicates that this condition is not diagnosed randomly or after only one failed treatment; rather, it is identified after multiple unsuccessful attempts with different medications. According to various studies, epilepsy is classified as treatment-resistant when seizures remain uncontrolled despite the use of well-chosen antiepileptic drugs, administered in the correct doses and for a sufficient duration. This suggests that the problem is not due to poor medication adherence or inappropriate drug selection; instead, the brain itself does not respond to the treatment.
The same research indicates these patients continue to have seizures, both in terms of frequency and severity, negatively affecting their daily lives and rendering conventional pharmacological treatments inadequate.
How does vagus nerve stimulation for epilepsy work?
Vagus nerve stimulation works on the principle of neuromodulation, where abnormal electrical activity in the brain is affected by regular peripheral stimulation of the vagus nerve, without direct intervention in the brain tissue, by implanting an electrical device under the skin in the chest area, connected to a wire that wraps around the left vagus nerve in the neck, and this device sends periodic and pre-programmed electrical impulses that travel through the vagus nerve towards the central nervous system.
These signals do not target one specific area of the brain, but rather affect broad neural networks, which explains its effectiveness in cases where epilepsy is multifocal or not of precisely defined origin.
Which patients are candidates for vagus nerve stimulation?
Vagal stimulation for epilepsy is not suitable for all epilepsy patients, but is reserved for specific groups based on the nature of the epilepsy and previous treatment response:
- Patients with drug-resistant epilepsy: The primary candidates for vagus nerve stimulation are patients with drug-resistant epilepsy
- Patients unsuitable for ablative surgery: Vagus nerve stimulation therapy is commonly used in patients who are not suitable for ablative epilepsy surgery, including:
- The source of the seizures is not precisely identified
- Multifocal epilepsy
- The epileptic focus is located in sensitive brain regions that cannot be safely surgically removed
- Patients with multiple seizure types: This procedure can be used in patients with different types of seizures, whether specific to one area of the brain (Unifocal) or multifocal, only if the epilepsy does not respond to drug therapy.
- Patients who are capable of long-term follow-up: Vagus nerve stimulation for epilepsy requires constant monitoring and gradual adjustment of the device settings. So, it is not suitable for patients with commitments that prevent them from visiting their doctor from time to time.
To summarize, VNS therapy is suitable for cases where the disease does not respond to drug therapy or where ablative surgery is contraindicated, and the patient must be committed to the doctor’s prescribed treatment plan.
Benefits of vagus nerve stimulation for epilepsy
Recent research is unanimous that the primary benefit of vagus nerve stimulation is to:
- Reduced seizure frequency: The primary benefit of vagus nerve stimulation is a reduction in seizure frequency in a very large proportion of patients with drug-resistant epilepsy.
- Gradual improvement over time: The effectiveness of vagus nerve stimulation is not constant, but tends to improve over the medium and long term. The response to treatment can increase as stimulation continues and device settings are adjusted, which is an important advantage compared to some other treatment options with a fixed effect.
- Reduced seizure severity: Vagus nerve stimulation can not only reduce the number of seizures but also lower their severity, resulting in fewer seizure-related complications.
- Improved quality of life: Reducing the frequency and severity of seizures positively affects patients’ quality of life. Even when complete seizure control is not achieved, patients have been observed to experience improvements in their daily functioning and adaptability.
- Non-ablative epilepsy treatment: Vagus nerve stimulation offers the advantage of not requiring the removal of any brain tissue. This makes it a suitable option for patients who are not candidates for ablative surgery or whose seizure source is not precisely identified.
- Can be used in conjunction with drug therapy: Vagus nerve stimulation can be used in parallel with antiepileptic drugs, without the need to stop drug therapy, allowing treatments to complement rather than replace each other.
- Individualized treatment adjustability: VNS settings can be gradually adjusted based on each patient’s response, providing therapeutic flexibility and helping achieve a better balance between effectiveness and side effects.
Risks and possible side effects of vagus nerve stimulation
Although vagus stimulation for epilepsy is a procedure that avoids brain surgery, it carries some risks and potential complications.
Side effects associated with electrical stimulation
The most common side effects of vagus nerve stimulation are related to the electrical stimulation periods and are fortunately not permanent.
- hoarseness
- Changes in tone of voice during stimulation
- Discomfort in the throat or neck
These symptoms typically occur when the device is powered on, can be reduced by adjusting the settings, and vanish when the device is turned off.
Coughing and mild breathing disorders
Some patients may experience coughing or mild respiratory distress during periods of stimulation, but these are mild and tolerable, so they do not require stopping treatment.
Swallowing disorders
In some very rare cases, patients may experience mild difficulty swallowing, especially in the early stages of using the device, but this is minor and does not require stopping treatment.
Localized pain or discomfort
Some patients may experience localized pain or discomfort at the device implant site or along the nerve wire pathway, but this is limited and short-lived after implantation.
Surgical risks associated with device implantation
Vagus nerve stimulator implantation is a minimally invasive procedure, but it may be associated with common risks such as:
- Pain after surgery
- Potential for localized infection
- Wound-related complications
But these risks are uncommon and can often be managed medically.
The need to adjust settings
Some side effects may require an adjustment in the intensity or pattern of stimulation instead of stopping the treatment altogether. While some individuals may find this adjustment unpleasant, it’s important to understand that modifying the settings to minimize potential risks is a key aspect of the treatment’s safety protocol.
The difference between vagus nerve stimulation and conventional surgery for epilepsy
| Comparison | Vagus nerve stimulation for epilepsy | Conventional surgery for epilepsy |
|---|---|---|
| The nature of the procedure | Neuromodulation through electrical stimulation of the vagus nerve without removing brain tissue | A surgical procedure based on removing an epileptic focus from the brain |
| Interfering with brain tissue | Does not involve any resection or direct intervention in the brain | It requires removing part of the brain tissue responsible for the seizures |
| Convenience for patients | Suitable for patients with drug-resistant epilepsy who are not eligible for ablative surgery | Suitable for patients in whom a clear and resectable epileptic focus can be identified |
| Identify the source of the seizures | A single epileptogenic focus does not have to be precisely identified | Requires accurate identification of the source of the seizures |
| Types of epilepsy | It can be used in multifocal or nonspecific epilepsy | Often used in specific focal epilepsy |
| Therapeutic goal | Reducing the frequency and severity of seizures without guaranteeing their complete disappearance | It may aim to completely control seizures in some cases |
| Reversibility of the procedure | Stimulation can be turned off, or the device can be removed when needed | Non-reversible action |
| Evolution of effectiveness over time | Efficacy may gradually improve over time | The surgical effect is stable after the procedure |
| Neurological hazards | Not associated with direct brain damage, according to research | Associated with potential risks resulting from the removal of brain tissue |
| Therapeutic role | Adjunctive therapy used in conjunction with medications | It may be a definitive treatment in selected cases |
Vagus nerve stimulation for epilepsy steps
Vagus nerve stimulation for epilepsy is a step-by-step process that includes pre-surgical evaluation, device fitting, device programming, and periodic follow-up.
Clinical assessment before the procedure
The initiation of vagus nerve stimulation for epilepsyis preceded by a thorough medical evaluation to ensure the patient’s suitability for this type of treatment. This includes confirming the diagnosis of drug-resistant epilepsy, reviewing previous treatment history, ensuring that the patient is not a suitable candidate for ablative surgery for epilepsy, and determining the goal of treatment, which is to reduce the frequency or severity of seizures, not to achieve a complete cure.
Vagus nerve stimulator implantation
The VNS device is implanted through a minimally invasive surgical procedure. The electrical pulse generator is implanted under the skin in the chest area and is connected to a wire (electrode) that wraps around the left vagus nerve in the neck. This procedure does not involve any direct intervention on the brain tissue or removal of any part of the brain.
Postoperative period
The device is usually not activated immediately after implantation; a short wait is recommended to allow the wound to heal and minimize local discomfort before starting stimulation.
Device Activation and Programming
In this step, the vagus nerve stimulation device is activated, its settings adjusted, and the intensity, duration, and frequency of the pulses are gradually determined to minimize side effects and achieve the best possible response.
Gradual adjustment and follow-up
The treatment is not based on fixed settings, but requires periodic follow-up during which the device’s settings are adjusted based on the patient’s response to seizures and tolerance to stimulation.
In conclusion, vagus nerve stimulation for epilepsy offers an important supportive option for individuals who have not achieved sufficient seizure control with medication alone. Gaining a clear understanding of how this therapy works empowers patients and their families to make informed decisions as part of a comprehensive treatment plan. Within this framework, Bimaristan Medical Center plays a key role by providing thorough evaluations and modern therapeutic options in a specialized medical setting tailored to each patient’s needs.
Sources:
- Vagus nerve stimulation therapy for epilepsy. (2019). Epilepsy & Behavior.
- Vagus nerve stimulation in epilepsy: Mechanisms, clinical outcomes, and future perspectives. (2024). Frontiers in Neurology.
- Long-term outcomes and optimization of vagus nerve stimulation therapy in drug-resistant epilepsy. (2024). Neuromodulation.